HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells.

Abstract
The lack of a cure for metastatic castrate-resistant prostate cancer (mCRPC) highlights the urgent need for more efficient drugs to fight this disease. Here, we report the mechanism of action of the natural product 6α-acetoxyanopterine (6-AA) in prostate cancer cells. At low nanomolar doses, this potent cytotoxic alkaloid from the Australian endemic tree Anopterus macleayanus induced a strong accumulation of LNCaP and PC-3 (prostate cancer) cells as well as HeLa (cervical cancer) cells in mitosis, severe mitotic spindle defects, and asymmetric cell divisions, ultimately leading to mitotic catastrophe accompanied by cell death through apoptosis. DNA microarray of 6-AA-treated LNCaP cells combined with pathway analysis identified very similar transcriptional changes when compared with the anticancer drug vinblastine, which included pathways involved in mitosis, microtubule spindle organization, and microtubule binding. Like vinblastine, 6-AA inhibited microtubule polymerization in a cell-free system and reduced cellular microtubule polymer mass. Yet, microtubule alterations that are associated with resistance to microtubule-destabilizing drugs like vinca alkaloids (vinblastine/vincristine) or 2-methoxyestradiol did not confer resistance to 6-AA, suggesting a different mechanism of microtubule interaction. 6-AA is a first-in-class microtubule inhibitor that features the unique anopterine scaffold. This study provides a strong rationale to further develop this novel structure class of microtubule inhibitor for the treatment of malignant disease. Mol Cancer Ther; 16(1); 3-15. ©2016 AACR.
AuthorsClaire Levrier, Martin C Sadowski, Anja Rockstroh, Brian Gabrielli, Maria Kavallaris, Melanie Lehman, Rohan A Davis, Colleen C Nelson
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 16 Issue 1 Pg. 3-15 (01 2017) ISSN: 1538-8514 [Electronic] United States
PMID27760837 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2016 American Association for Cancer Research.
Chemical References
  • Antimitotic Agents
  • Antineoplastic Agents
  • Biological Products
  • Tubulin
  • Tubulin Modulators
  • Vinblastine
Topics
  • Antimitotic Agents (chemistry, pharmacology)
  • Antineoplastic Agents (chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Biological Products (chemistry, pharmacology)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Gene Expression Profiling
  • Humans
  • Male
  • Microtubules (metabolism)
  • Mitosis (drug effects, genetics)
  • Prostatic Neoplasms (metabolism)
  • Protein Multimerization (drug effects)
  • Spindle Apparatus (drug effects)
  • Tubulin (chemistry, metabolism)
  • Tubulin Modulators (chemistry, pharmacology)
  • Vinblastine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: